Biocon Ltd.

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
29-Apr-21 Motilal Oswal Approvals/faster traction to lead to better future growth Neutral 394 390 -1.02
29-Apr-21 Isec Biosimilars performance below expectations… Buy 391 400 2.3
22-Oct-18 Motilal Oswal Positive Committee opinion Neutral 658 625 -5.02
24-Sep-18 Motilal Oswal Favorable regulatory outcome enhances biosimilars prospects Buy 665 625 -6.02
11-Apr-18 SPA Securities Front runner in Biosimilars to guide revenues going ahead 612

Upcoming Events and Recent Updates

08-Apr-24
Post ITs (Interesting Article) - Biocon leads India push into weight loss drugs as patents lapse  ( updated on Apr 08 2024)

Analyst Calls / Meets


Management Interviews

18-Dec-23 Siddharth Mitta..  
20-Sep-23 Kiran Mazumdar ..  
25-Apr-23 Kiran Mazumdar ..  
15-Feb-23 Kiran Mazumdar ..  
21-Jun-22 Kiran Mazumdar ..  

Investor Presentations

17-Nov-23 Investor/Anal...
11-Aug-23 Investor/Anal...
23-May-23 Investor/Anal...
20-Feb-23 Investor/Anal...
15-Nov-22 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2022-23  
2021-22  
2020-21  
2019-20  
2018-19  

Research Showcase

29-Apr-21
Motilal Oswal -..
Download
29-Apr-21
Isec - Quarter ..
Download
22-Oct-18
Motilal Oswal -..
Download
24-Sep-18
Motilal Oswal -..
Download
11-Apr-18
SPA Securities ..
Download

Results

09-Feb-24 Results
10-Nov-23 Results
11-Aug-23 Results
14-Feb-23 Results
14-Nov-22 Results

AGM/EGM/Board Meetings

24-Jul-20 - AGM
23-Jul-20 - Quarterly Results
14-May-20 - Audited Results
23-Jan-20 - Quarterly Results
26-Jul-19 - AGM

Press Release

09-Feb-24 Press Release
10-Nov-23 Press Release
11-Aug-23 Press Release
24-Jul-23 Press Release
24-May-23 Press Release

 

Archived Documents

No Archieved Transcript.